Leerink Is Back On Board The Biotech Train
February 05, 2016 at 10:32 AM EST
Leerink has restarted coverage on eight large-cap biotech stocks following a prolonged period of share price underperformance. In a new ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.